0000000000557593

AUTHOR

Manuel Arrojo

showing 35 related works from this author

White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?

2019

Supported by the European Community’s Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI)

SYMPTOMSCommunity Assessment of Psychic ExperiencesPsychotic disorder0302 clinical medicinecognitive abilitylcsh:PsychiatrySCHIZOPHRENIASalut mentalOriginal Researchmedia_commonPsychiatryCognitive abilityCognition16. Peace & justiceCHILDHOOD TRAUMAPsychiatry and Mental healthSchizophreniaRELIABILITYTraitHALLUCINATIONSClinical psychologyInfàncialcsh:RC435-571media_common.quotation_subjectIllusionQUESTIONNAIREPsicosiLife events03 medical and health scienceschildhood adversityTHREATENING EXPERIENCESmedicinePsiquiatriaSiblingVALIDITYAssociation (psychology)White noise speech illusionsENVIRONMENTwhite noise speech illusionsbusiness.industrySHORT-FORMPsychosesOdds ratiopsychotic disordermedicine.diseaseChildhoodConfidence interval030227 psychiatrylife eventsTrastorns de la parlaChildhood adversitybusiness030217 neurology & neurosurgery
researchProduct

The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI)

2020

Funder: FP7 Ideas: European Research Council; doi: http://dx.doi.org/10.13039/100011199; Grant(s): HEALTH-F2-2010-241909

MaleHealth (social science)EpidemiologyEthnic groupEthnic GroupGene-environment interactionsEnvironment–environment interactions0302 clinical medicineEpidemiologyEthnicity10. No inequalityFirst episodeRISKbiologyIncidence (epidemiology)IncidenceCANNABISMiddle AgedCase-controlFirst-episode psychosis3. Good healthEuropePsychiatry and Mental healthCase–control Environment–environment interactions EU-GEI First-episode psychosis Gene–environment interactions IncidenceCase–control; EU-GEI; Environment–environment interactions; First-episode psychosis; Gene–environment interactions; IncidenceSchizophreniaCohortFemalePsychologyCase-Control StudieCase–controlBrazilHumanAdultmedicine.medical_specialtySocial PsychologyAdolescentStudy Protocols and SamplesDISORDERSEnvironment–environment interactionRepresentativeness heuristicEU-GEIGene–environment interactions03 medical and health sciencesYoung AdultPSYCHOSISAGEFirst-episode psychosiEnvironment-environment interactionsmedicineHumansGene–environment interactionSettore MED/25 - PsichiatriaMETAANALYSISbiology.organism_classificationmedicine.disease030227 psychiatryCase-Control StudiesSchizophreniaGene-Environment InteractionCannabisCHILDHOOD ADVERSITIES030217 neurology & neurosurgeryDemographySocial Psychiatry and Psychiatric Epidemiology
researchProduct

Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

2019

Background\ud The value of the nosological distinction between non-affective and affective psychosis has frequently been challenged. We aimed to investigate the transdiagnostic dimensional structure and associated characteristics of psychopathology at First Episode Psychosis (FEP). Regardless of diagnostic categories, we expected that positive symptoms occurred more frequently in ethnic minority groups and in more densely populated environments, and that negative symptoms were associated with indices of neurodevelopmental impairment.\ud \ud Method\ud This study included 2182 FEP individuals recruited across six countries, as part of the EUropean network of national schizophrenia networks st…

AdultAffective Disorders PsychoticMaleBipolar Disorder[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyBifactor modelPsicosiModels Psychologicalsymptom dimensionsPathological psychologyYoung AdultSettore M-PSI/08 - Psicologia Clinicafirst episode psychosisSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansSettore MED/25 - PsichiatriaComputingMilieux_MISCELLANEOUSPsychiatric Status Rating ScalesPsychopathology[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behaviorDepression[SCCO.NEUR]Cognitive science/NeurosciencePsychoses[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesBifactor model; diagnostic categories; first episode psychosis; psychopathology; symptom dimensionsOriginal Articlespsychopathologydiagnostic categoriesPsicopatologiaEuropediagnostic categoriePsychotic DisordersROC Curvefirst episode psychosiSchizophreniaFemaleSchizophrenic PsychologyEsquizofrènia
researchProduct

Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis

2023

The European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) Project is funded by grant agreement HEALTH-F2-2010-241909 (Project EU-GEI) from the European Community’s Seventh Framework Programme.

SCHIZOPHRENIA SPECTRUMmedicine.medical_specialtyGENESpolygenic riskfirst-episode psychosiILLNESSinteraction contrast ratioChildhood traumaDOPAMINEFirst episode psychosisSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MALTREATMENTMedicinefirst-episode psychosisABUSEPsychiatrySettore MED/25 - PsichiatriaApplied PsychologyTRAUMAENVIRONMENTbusiness.industrymedicine.diseaseschizophreniaPsychiatry and Mental healthSchizophreniaRELIABILITYPolygenic risk scoresynergistic effectsbusinessPsychological medicine
researchProduct

Migration history and risk of psychosis: results from the multinational EU-GEI study.

2022

The European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) Project was funded by grant agreement Health-F2-2010-241909 (Project EU-GEI) from the European Community’s Seventh Framework programme.

Psychosismedicine.medical_specialtyESTUDOS DE CASOS E CONTROLESEthnic groupLogistic regressionIMMIGRANTSFAMILY-HISTORYfirst-generation migrantsOdds03 medical and health sciences0302 clinical medicineFirst-episode psychosifirst-generation migrantSCHIZOPHRENIAmedicinemigration adversities[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]1ST-EPISODE PSYCHOSISINTERNAL MIGRATIONApplied PsychologyCumulative effectComputingMilieux_MISCELLANEOUSmigration historypsychosis riskbusiness.industryPublic healthmigration adversitieSDG 10 - Reduced InequalitiesFirst-episode psychosismedicine.diseaseCHILDHOOD TRAUMA030227 psychiatry3. Good healthETHNICITYPsychiatry and Mental healthsocial disadvantagesSchizophreniaMultinational corporation/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalities1ST-CONTACT INCIDENCE[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]businesssocial disadvantages.MENTAL-HEALTHSOCIAL DISADVANTAGE030217 neurology & neurosurgeryDemography
researchProduct

Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study

2021

AbstractBackgroundPerceived discrimination is associated with worse mental health. Few studies have assessed whether perceived discrimination (i) is associated with the risk of psychotic disorders and (ii) contributes to an increased risk among minority ethnic groups relative to the ethnic majority.MethodsWe used data from the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2, a population-based case−control study of incident psychotic disorders in 17 catchment sites across six countries. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) for the associations between perceived discrimination and psychosis using mixed-…

Mediation (statistics)LIFE EVENTSMIGRATIONPopulationEthnic groupLogistic regressionpsychosiOdds03 medical and health sciences0302 clinical medicineMINORIAS ÉTNICASSCHIZOPHRENIAMedicinepsychosisfirst-episodeeducationCase−controlApplied PsychologyTRAUMACase-control discrimination first-episode minority ethnic group multi-country psychosis psychotic disorderFirst episodemulti-countryeducation.field_of_studyminority ethnic groupCONSEQUENCESbusiness.industryAbsolute risk reductionPATHWAYSOdds ratiopsychotic disorderCase-controlMEDIATION ANALYSIS030227 psychiatryPsychiatry and Mental health[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]HEALTHbusinessCHILDHOOD ADVERSITIES030217 neurology & neurosurgeryDemographydiscrimination
researchProduct

Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum

2020

The EUGEI project was supported by the European Community’s Seventh Framework Program under grant agreement no. HEALTH-F2-2009-241909 (Project EU-GEI). Dr O’Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/ L010305/1). Dr Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation. Drs Guloksuz and van Os are supported by the Ophelia research project, ZonMw grant number: 636340001. Dr Arango was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024); CIBERSAM; Madrid Regional Government (B2017/BMD-3740, AGES-CM-2); Fundación Familia Alonso and Fundac…

AdultMaleExposomePsychosisMultifactorial InheritanceEpidemiologyBIRTHSchizotypystructured interviewGENE-ENVIRONMENTPopulationschizotypypopulationEnvironment03 medical and health sciences0302 clinical medicineMedicineHumansSpectrum disorderGenetic Predisposition to DiseasegeneticspsychosiseducationMETAANALYSISvalidationRISKeducation.field_of_studychildhood traumareliabilitybusiness.industryPublic Health Environmental and Occupational HealthAbsolute risk reductionassociationRegression analysisGenomicsmedicine.disease3. Good health030227 psychiatryPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleGene-Environment InteractionSchizophrenic PsychologyOriginal Articlebusiness030217 neurology & neurosurgeryClinical psychologyEpidemiology and Psychiatric Sciences
researchProduct

Spanish validation of the Empirically Developed Clinical Staging Model (EmDe-5) for patients with bipolar disorder

2021

Abstract Introduction Bipolar disorder (BD) has been reconceptualised as a progressive disorder that develops from mild to severe presentations. An empirical staging model – the Empirically Developed Clinical Staging Model for BD (EmDe-5) – was developed in a previous study. This study aims to further validate that model using a larger and more representative Spanish sample. Material and methods 183 BD outpatients were recruited at 11 sites in Spain. Assessment included clinical characteristics of the BD (number of hospitalisations, number of suicide attempts, comorbid personality disorders), physical health (BMI, metabolic syndrome, number of physical illnesses), cognition (SCIP), function…

Pediatricsmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectConstruct validityCognitionmedicine.diseasePersonality disordersPsychiatry and Mental healthQuality of lifeProgressive disorderMedicinePersonalityBipolar disorderStage (cooking)businessmedia_commonRevista de Psiquiatría y Salud Mental
researchProduct

Association Study of Nonsynonymous Single Nucleotide Polymorphisms in Schizophrenia

2010

Genome-wide association studies using several hundred thousand anonymous markers present limited statistical power. Alternatively, association studies restricted to common nonsynonymous single nucleotide polymorphisms (nsSNPs) have the advantage of strongly reducing the multiple testing problem, while increasing the probability of testing functional single nucleotide polymorphisms (SNPs).We performed a case-control association study of common nsSNPs in Galician (northwest Spain) samples using the Affymetrix GeneChip Human 20k cSNP Kit, followed by a replication study of the more promising results. After quality control procedures, the discovery sample consisted of 5100 nsSNPs at minor allel…

AdultMaleNonsynonymous substitutionGenotype"psychosis"methods [Genetic Association Studies]"mental brain homeostasis"Single-nucleotide polymorphismBiologygenetics [Cation Transport Proteins]Polymorphism Single Nucleotide03 medical and health sciences0302 clinical medicineHumansGenetic Predisposition to Diseasegenetics [Schizophrenia]ddc:610statistics & numerical data [Genetic Association Studies]genetics [Genetic Predisposition to Disease]Cation Transport ProteinsGenetic Association StudiesBiological PsychiatryAged030304 developmental biology"ZIP8"Aged 80 and overGenetics0303 health sciences"mental brain homeostasis"; "psychosis"; "metal ion transporters"; "ZIP8"; "whole-genome assosiation"; "SLC39A3"Zip8 protein humanMiddle Aged3. Good health"whole-genome assosiation"SpainCase-Control StudiesSchizophreniaFemale"SLC39A3""metal ion transporters"030217 neurology & neurosurgeryBiological Psychiatry
researchProduct

Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI).

2022

[Background and hypothesis] Evidence suggests that childhood maltreatment (ie, childhood abuse and childhood neglect) affects educational attainment and cognition. However, the association between childhood maltreatment and Intelligence Quotient (IQ) seems stronger among controls compared to people with psychosis. We hypothesised that: the association between childhood maltreatment and poor cognition would be stronger among community controls than among people with first-episode of psychosis (FEP); compared to abuse, neglect would show stronger associations with educational attainment and cognition; the association between childhood maltreatment and IQ would be partially accounted for by ot…

Affective Disorders PsychoticIntelligence TestsSTRESSchildhood abuseBIPOLAR DISORDERASSOCIATIONschizophreniaPsychiatry and Mental healthPsychotic DisordersIQADVERSITIESCase-Control StudiesONSETRELIABILITYPHYSICAL ABUSEHumanschildhood neglectpsychosisChild AbuseVALIDITYChildRegular ArticlesTRAUMA
researchProduct

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI s…

2021

Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid adjustment with symptom dimensions in a large first episode psychosis (FEP) sample. We used data from the international EU-GEI study. Bifactor modelling of the Operational Criteria in Studies of Psychotic Illness (OPCRIT) ratings provided general and specific symptom dimension scores. Premorbid Adjustment Scale estimated premorbid social (PSF) and academic adjustment (PAF), and WAIS-brief version measured IQ. A MANCOVA model examined the relationship between symptom di…

PsychosisFirst episode psychosiscognitive domainsPremorbid Adjustment ScaleQUOCIENTE DE INTELIGÊNCIATransdiagnostic Premorbid adjustmentNEGATIVE SYMPTOMSArticlesymptom dimensionspremorbid adjustmentWORKING-MEMORYSecondary analysisFirst episode psychosisfirst episode psychosis1ST-EPISODE NONAFFECTIVE PSYCHOSISMedicineScopusCognitive domain[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Settore MED/25 - PsichiatriaBiological PsychiatryTransdiagnosticbusiness.industryWorking memoryConfoundingCognitive domainsCognitionBIPOLAR DISORDERSymptom dimensionsmedicine.diseaseGENE-ENVIRONMENT INTERACTIONSFirst episode psychosiCANNABIS USEPsychiatry and Mental healthSymptom dimensionPerceptual reasoningJCRIQSOCIAL COGNITIONtransdiagnosticPROCESSING-SPEEDNEURODEVELOPMENTAL TRAJECTORIES[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Premorbid adjustmentbusinessSCHIZOAFFECTIVE DISORDERClinical psychology
researchProduct

A replication study of JTC bias, genetic liability for psychosis and delusional ideation

2022

The EUGEI project was supported by the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). Dr O'Donovan is supported by MRC programme grant (G08005009) and an MRC Centre grant (MR/L010305/1)

PsychosisfamilyHallucinationsCONVICTIONDecision Makingneuropsychology03 medical and health sciences0302 clinical medicineCognitionBiasmedicineHumansSpectrum disorderpsychosisSiblingVALIDITYAssociation (psychology)jumping to conclusionsApplied PsychologyNeuropsychologyCognitionmedicine.disease030227 psychiatryPsychiatry and Mental healthCONTINUUMPsychotic DisordersRelative riskJumping to conclusionsCONCLUSIONSRELIABILITYSchizophreniadelusionsreasoningPsychology030217 neurology & neurosurgeryClinical psychology
researchProduct

Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

2019

The EUGEI project was supported by the grant agreement HEALTH-F2-2010-241909 from the European Community’s Seventh Framework Programme. The authors are grateful to the patients and their families for participating in the project. They also thank all research personnel involved in the GROUP project, in particular J. van Baaren, E. Veermans, G. Driessen, T. Driesen, E. van’t Hag and J. de Nijs. Bart PF Rutten was funded by a VIDI award number 91718336 from the Netherlands Scientific Organisation.

MalecannabisLogistic regression0302 clinical medicineLasso (statistics)Adverse Childhood ExperiencesStatisticsOdds RatioChild AbusePOLYGENIC RISKpsychosisChildPsychiatrySUMMER BIRTHFramingham Risk Score3. Good healthExposomePsychiatry and Mental healthmachine learningSchizophreniaArea Under CurveFemaleMarijuana UseSeasonsEnvironment And Schizophrenia—Feature Editor: Jim van OsLife Sciences & Biomedicineenvironmentpredictive modelingAdultExposomeDISORDERSrisk scoreYoung Adult03 medical and health sciencesPSYCHOSISmedicineJournal ArticleHumansHearing LossMETAANALYSISDEFICIT SCHIZOPHRENIAENVIRONMENTModels StatisticalScience & Technologychildhood traumaReceiver operating characteristicbusiness.industrySiblingsBullyingBayes TheoremChild Abuse SexualOdds ratiohearing impairmentmedicine.disease030227 psychiatryschizophreniaLogistic ModelsROC CurveSexual abuseCase-Control StudiesbusinessCHILDHOOD ADVERSITIES030217 neurology & neurosurgerywinter birth
researchProduct

Pre-training inter-rater reliability of clinical instruments in an international psychosis research project.

2021

International audience

Research designPsychosisINFORMATIONIMPACTApplied psychologyMEDLINEAssessor selection Pre-training inter-rater reliability Psychosis instruments03 medical and health sciences0302 clinical medicineMedicineHumansBiological PsychiatryComputingMilieux_MISCELLANEOUSObserver VariationREPRODUTIBILIDADE DE RESULTADOSbusiness.industryPre-training inter-rater reliabilityReproducibility of Resultsmedicine.disease030227 psychiatryPsychiatry and Mental healthInter-rater reliabilityAssessor selectionTRIALSPsychotic DisordersResearch Design[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MEASUREMENT ERRORbusinessObserver variation030217 neurology & neurosurgeryPsychosis instrumentsSchizophrenia research
researchProduct

Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multi-Centre EU-GEI Case-Control Study

2019

AbstractBackgroundThe “jumping to conclusions” (JTC) bias is associated with both psychosis and general cognition but their relationship is unclear. In this study, we set out to clarify the relationship between the JTC bias, IQ, psychosis and polygenic liability to schizophrenia and IQ.Methods817 FEP patients and 1294 population-based controls completed assessments of general intelligence (IQ), and JTC (assessed by the number of beads drawn on the probabilistic reasoning “beads” task) and provided blood or saliva samples from which we extracted DNA and computed polygenic risk scores for IQ and schizophrenia.ResultsThe estimated proportion of the total effect of case/control differences on J…

education.field_of_studyMediation (statistics)PsychosisPopulationCognitionmedicine.diseaseCognitive bias030227 psychiatry03 medical and health sciences0302 clinical medicineSchizophreniaJumping to conclusionsmedicinemedicine.symptomeducationPsychology030217 neurology & neurosurgeryCognitive deficitClinical psychology
researchProduct

A polygenic approach to the association between smoking and schizophrenia.

2021

Smoking prevalence in schizophrenia is considerably larger than in general population, playing an important role in early mortality. We compared the polygenic contribution to smoking in schizophrenic patients and controls to assess if genetic factors may explain the different prevalence. Polygenic risk scores (PRSs) for smoking initiation and four genetically correlated traits were calculated in 1108 schizophrenic patients (64.4% smokers) and 1584 controls (31.1% smokers). PRSs for smoking initiation, educational attainment, body mass index and age at first birth were associated with smoking in patients and controls, explaining a similar percentage of variance in both groups. Attention-defi…

AdultPsychosisMultifactorial InheritanceSociodemographic FactorsPopulationMedicine (miscellaneous)Nerve Tissue ProteinsReceptors NicotinicGenetic correlationBody Mass IndexNicotineRisk Factorsmental disordersmedicineGenetic predispositionTobacco SmokingHumansGenetic Predisposition to DiseaseRisk factoreducationPharmacologyeducation.field_of_studybusiness.industryMiddle Agedmedicine.diseasePsychiatry and Mental healthPhenotypeSchizophreniaAttention Deficit Disorder with HyperactivitySchizophreniabusinessBody mass indexDemographymedicine.drugGenome-Wide Association StudyAddiction biologyREFERENCES
researchProduct

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study

2018

Importance: Psychotic disorders contribute significantly to the global disease burden, yet the latest international incidence study of psychotic disorders was conducted in the 1980s. Objectives: To estimate the incidence of psychotic disorders using comparable methods across 17 catchment areas in 6 countries and to examine the variance between catchment areas by putative environmental risk factors. Design, Setting, and Participants: An international multisite incidence study (the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions) was conducted from May 1, 2010, to April 1, 2015, among 2774 individuals from England (2 catchment areas), France (3 catch…

Male2.3 Psychological social and economic factorsSYMPTOMS[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiologyenvironmental risk factorsCatchment Area HealthRisk FactorsSCHIZOPHRENIADEPRIVATIONComputingMilieux_MISCELLANEOUShealth care economics and organizationsMinority Groups44 Human SocietyOriginal InvestigationNetherlands2 AetiologyOUTCOMES[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behaviorpsychotic disorders; international multisite incidence study; EU-GEI Study; environmental risk factorsIncidenceAge Factors[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesMental HealthEnglandItalyPsychiatry and Mental Health4206 Public Healthpopulation characteristicsFemaleFrancegeographic locationsBrazilAdultCross-Cultural ComparisonURBANICITYeducationAGESex Factorsparasitic diseasesHumans1ST-EPISODE PSYCHOSISRATESNOTTINGHAMinternational multisite incidence studyMETAANALYSISPublishingEU-GEI Study[SCCO.NEUR]Cognitive science/NeurosciencePrevention42 Health SciencesPsychotic DisordersSpainGene-Environment Interaction
researchProduct

Use of multiple Polygenic Risk Scores for distinguishing Schizophrenia-spectrum disorder and Affective psychosis categories; the EUGEI study

2021

ABSTRACTSchizophrenia (SZ), Bipolar Disorder (BD) and Depression (D) run in families. This susceptibility is partly due to hundreds or thousands of common genetic variants, each conferring a fractional risk. The cumulative effects of the associated variants can be summarised as a polygenic risk score (PRS). Using data from the EUGEI case-control study, we aimed to test whether PRSs for three major psychiatric disorders (SZ, BD, D) and for intelligent quotient (IQ) as a neurodevelopmental proxy, can discriminate affective psychosis (AP) from schizophrenia-spectrum disorder (SSD). Participants (573 cases, 1005 controls) of european ancestry from 17 sites as part of the EUGEI study were succes…

Affective psychosisPsychosisSchizophreniabusiness.industrymedicinePolygenic risk scorePsychotic depressionBipolar disordermedicine.diseasebusinessDepression (differential diagnoses)Clinical psychologyMultinomial logistic regression
researchProduct

The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Pro…

2020

Purpose: The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) study contains an unparalleled wealth of comprehensive data that allows for testing hypotheses about (1) variations in incidence within and between countries, including by urbanicity and minority ethnic groups; and (2) the role of multiple environmental and genetic risk factors, and their interactions, in the development of psychotic disorders. Methods: Between 2010 and 2015, we identified 2774 incident cases of psychotic disorders during 12.9 million person-years at risk, across 17 sites in 6 countries (UK, The Netherlands, France, Spain, Italy, and Brazil). Of the 2774 incident…

Esquizofrènia
researchProduct

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use

2020

Abstract Psychotic patients with a lifetime history of cannabis use generally show better cognitive functioning than other psychotic patients. Some authors suggest that cannabis-using patients may have been less cognitively impaired and less socially withdrawn in their premorbid life. Using a dataset comprising 948 patients with first-episode psychosis (FEP) and 1313 population controls across 6 countries, we examined the extent to which IQ and both early academic (Academic Factor [AF]) and social adjustment (Social Factor [SF]) are related to the lifetime frequency of cannabis use in both patients and controls. We expected a higher IQ and a better premorbid social adjustment in psychotic p…

MalecognitionIntelligenceComorbiditySUBSTANCE USE DISORDERS0302 clinical medicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MedicinePREDICTORSRISKeducationeducation.field_of_studybiologyCognitionMiddle AgedPsychosocial FunctioningsociabilityPsychiatry and Mental healthSchizophreniaFemaleMarijuana UseSocial AdjustmentMENTAL-HEALTHAdultmedicine.medical_specialtyPsychosisAdolescentPopulation1ST EPISODEDRUG-USEpreillnessSettore MED/01 - Statistica MedicaYoung Adult03 medical and health sciencesAGESettore M-PSI/08 - Psicologia ClinicaHumansCognitive skilleducationPsychiatrySettore MED/25 - Psichiatriabusiness.industryCase-control studypreillnebiology.organism_classificationmedicine.diseaseEDUCAÇÃO030227 psychiatryschizophreniaPsychotic DisordersCase-Control StudiesONSETCannabisNEUROCOGNITIONbusinessmarijuanaNeurocognitive030217 neurology & neurosurgeryRegular ArticlesSchizophrenia Bulletin
researchProduct

The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control an…

2019

Background: Some recent studies have challenged the direction of causality for the association between cannabis use and psychotic disorder, suggesting that cannabis use initiation is explained by common genetic variants associated with risk of schizophrenia. We used data from the European Union Gene-Environment Interaction consortium (EUGEI) case-control study to test for the independent and combined effect of heavy cannabis use, and of Schizophrenia Polygenic risk score (SZ PRS), on risk for psychotic disorder. Methods: Genome-wide data were obtained from 492 first episode psychosis patients (FEPp) and from 787 controls of European Ancestry, and used to generate SZ PRS from the summary res…

medicine.medical_specialtybiologybusiness.industryFrequency of useCannabis usebiology.organism_classificationmedicine.disease030227 psychiatry3. Good health03 medical and health sciences0302 clinical medicineSchizophreniaFirst episode psychosisCase control analysisMedicinemedia_common.cataloged_instancePolygenic risk scoreCannabisEuropean unionbusinessPsychiatry030217 neurology & neurosurgerymedia_common
researchProduct

Jumping to conclusions, general intelligence, and psychosis liability: Findings from the multi-centre EU-GEI case-control study

2021

This study was funded by the Medical Research Council, the European Community’s Seventh Framework Program grant [agreement HEALTH-F2-2009-241909 (Project EU-GEI)], São Paulo Research Foundation (grant 2012/0417-0), the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London, the NIHR BRC at University College London and the Wellcome Trust (grant 101272/Z/12/Z).

MaleMISCOMPREHENSIONIntelligenceDELÍRIO0302 clinical medicineCognitionSCHIZOPHRENIApsychotic-like experiencejumping to conclusionsApplied PsychologyProblem SolvingRISKeducation.field_of_studyCognitionMiddle Aged16. Peace & justiceCognitive bias3. Good healthFirst episode psychosis; IQ; jumping to conclusions; polygenic risk score; psychotic-like experiences; symptom dimensionsPsychiatry and Mental healthBIASSchizophreniaRELIABILITYFemaleOriginal Articlejumping to conclusion[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]medicine.symptomClinical psychologyAdultPsychosisFirst episode psychosisAdolescentDISORDERSPopulationREEXAMINATIONDelusionssymptom dimensions03 medical and health sciencesYoung AdultPEOPLEmedicineHumansCognitive DysfunctioneducationDELUSIONAL IDEATIONCognitive deficitpsychotic-like experiencesbusiness.industryCase-control studymedicine.diseaseFirst episode psychosi030227 psychiatryPsychotic DisordersIQCase-Control StudiesJumping to conclusionspolygenic risk scorebusiness030217 neurology & neurosurgeryPsychological medicine
researchProduct

Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: Results from the EU-GEI case-control study

2021

The European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) Project was funded by grant agreement Health-F2-2010-241909 (Project EU-GEI) from the European Community’s Seventh Framework programme. The Brazilian study was funded by grant 2012-0417-0 from the São Paulo Research Foundation. Dr Jongsma is funded by the Economic and Social Research Council (grant ES/S011714/1). Dr Kirkbride is funded by the Wellcome Trust and Royal Society (Grant 101272/Z/13/Z). Dr Jongsma and Professor Jones are funded by the National Institute of Health Research Collaboration of Leadership in Applied Health Research and Care East of England. Professor Rutten is funded…

MaleSocial Determinants of HealthEthnic groupPoison controlIMMIGRANTSOccupational safety and health0302 clinical medicinepsychotic disordersSCHIZOPHRENIADiscriminationOdds RatioApplied PsychologyRISKHYPOTHESISCommunication BarriersLinguistic distanceMiddle AgedDiscrimination; epidemiology; ethnicity; psychotic disorders; social disadvantage3. Good healthSocial researchEuropePsychiatry and Mental healthMIGRANT GROUPSethnicityFemaleepidemiologySTRIATAL DOPAMINE FUNCTIONAdultAdolescentDISORDERSsocial disadvantage1ST EPISODEBlack PeopleLibrary scienceTRANSTORNOS PSICÓTICOSWhite PeopleYoung Adult03 medical and health sciencesFirst episode psychosisPolitical scienceHumansMinority statusINCIDENCE RATESHealth Status DisparitiesOriginal Articlespsychotic disorder030227 psychiatryCase-Control StudiesEthnic and Racial MinoritiesIDENTITYGene-Environment InteractionSocial disadvantage030217 neurology & neurosurgery
researchProduct

Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway

2022

AbstractBackgroundThere is evidence that environmental and genetic risk factors for schizophrenia spectrum disorders are transdiagnostic and mediated in part through a generic pathway of affective dysregulation.MethodsWe analysed to what degree the impact of schizophrenia polygenic risk (PRS-SZ) and childhood adversity (CA) on psychosis outcomes was contingent on co-presence of affective dysregulation, defined as significant depressive symptoms, in (i) NEMESIS-2 (n = 6646), a representative general population sample, interviewed four times over nine years and (ii) EUGEI (n = 4068) a sample of patients with schizophrenia spectrum disorder, the siblings of these patients and controls.ResultsT…

RiskMultifactorial InheritancePsychosisHallucinationsAffective pathwayCLINICAL PSYCHOSISNEGATIVE SYMPTOMSDelusions03 medical and health sciences0302 clinical medicineMENTAL-HEALTH SURVEYchildhood adversityAffective dysregulationHumansMedicinegeneticspsychosisGenetic riskApplied Psychology1ST EPISODE PSYCHOSISGENERAL-POPULATIONbusiness.industryPSYCHIATRIC-DISORDERSSHORT-FORMAbsolute risk reductionNETWORK APPROACHIdeationmedicine.diseaseCHILDHOOD TRAUMA030227 psychiatryPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaSCHIZOPHRENIA SPECTRUM DISORDERSPolygenic risk scorebusinessenvironment030217 neurology & neurosurgerySchizophrenia spectrumClinical psychologyPsychological Medicine
researchProduct

Early Parental Death and Risk of Psychosis in Offspring: A Six-Country Case-Control Study

2019

Evidence for early parental death as a risk factor for psychosis in offspring is inconclusive. We analyzed data from a six-country, case-control study to examine the associations of early parental death, type of death (maternal, paternal, both), and child’s age at death with psychosis, both overall and by ethnic group. In fully adjusted multivariable mixed-effects logistic regression models, experiencing early parental death was associated with 1.54-fold greater odds of psychosis (95% confidence interval (CI): 1.23, 1.92). Experiencing maternal death had 2.27-fold greater odds (95% CI: 1.18, 4.37), paternal death had 1.14-fold greater odds (95% CI: 0.79, 1.64), and both deaths had 4.4…

ESTUDO DE CASOSTRESSCHILDHOODlcsh:Medicinechildhood adversitiespsychosiParental Death0302 clinical medicinePsicosi en els infantsSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.Medicineearly parental deathpsychosisDolRACEGeneral MedicineInfants Salut mentalchildhood adversitieEsquizofrèniaMaternal deathHEALTHcase-controlearly bereavementDISORDERSOffspringDISADVANTAGEethnic minoritiesethnic minoritieArticleOdds03 medical and health sciencesBEREAVEMENTJournal ArticleMortalitatPsiquiatriaMortalityRisk factorSettore MED/25 - PsichiatriaMETAANALYSISmulti-countrybusiness.industryMORTALITYlcsh:RCase-control studyOdds ratiomedicine.diseaseConfidence interval030227 psychiatrypopulation-basedschizophreniaPsychoses in childrenbusiness030217 neurology & neurosurgeryBereavementDemographyJournal of Clinical Medicine
researchProduct

Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia

2022

The EU-GEI Project was funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). The Brazilian study was funded by the Säo Paulo Research Foundation under grant number 2012/0417-0.

Emotions1ST-EPISODE SCHIZOPHRENIADEFICITSfacial affect recognition genetic liability first episode psychosisfirst episode psychosisSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCLINICAL HIGH-RISKSettore MED/25 - PsichiatriaPsychiatric Status Rating ScalesDepressive Disorder MajorARCHITECTUREPERCEPTIONIDENTIFICATIONUNAFFECTED SIBLINGSBIPOLAR DISORDERFacial ExpressionINDIVIDUALSPsychiatry and Mental healthPsychotic Disordersfacial affect recognitionCase-Control StudiesRELIABILITYSchizophreniaFacial Recognitiongenetic liabilitySchizophrenia bulletin
researchProduct

Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

2022

The EUGEI project was supported by the European Community’s Seventh Framework Program under grant agreement No. HEALTH-F2- 2009-241909 (Project EU-GEI). Dr. Arango was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16-PE07CP1, PI16/02012, PI19/024); CIBERSAM (...)

AdultMalePsychosisGENETIC RISKInterviews as Topic03 medical and health sciencesSTRUCTURED INTERVIEW0302 clinical medicinePolygenic risk scoreRisk FactorsSocial cognitionIMPUTATIONmedicineHumansPOLYGENIC RISKEmotion recognitionAssociation (psychology)Biological PsychiatryEmotionPharmacologyIntermediate phenotypebusiness.industrySiblingsUNAFFECTED SIBLINGSRegression analysisASSOCIATIONGenomicsmedicine.diseaseSocial cognition030227 psychiatrySchizotypal traitsINDIVIDUALSPolygenic risk scoresPhenotypePsychotic DisordersSchizophreniaRELIABILITYStructured interviewSchizophreniaFemalebusinessFacial Recognition030217 neurology & neurosurgeryClinical psychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample…

2022

This work was supported by funding from the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI). (...) CA was supported by the Spanish Ministry of Science and Innovation; Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), Fundación Familia Alonso and Fundación Alicia Koplowitz. MB was supported by the Ministry of Economy and Competitivity (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – ERDF Funds from the European Commission, ‘A way of making Europ…

bipolar disorderAffective psychosisdiagnosisGENETIC-RELATIONSHIPSschizophrenia-spectrum disorderPsychiatry and Mental healthAffective psychosis bipolar disorder diagnosis genetics polygenic score psychosis psychotic depression schizophrenia-spectrum disorderLIABILITYpsychotic depressiongeneticspolygenic scorepsychosisGENOME-WIDE ASSOCIATIONApplied PsychologyPsychological Medicine
researchProduct

The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study

2021

The influence of psychosocial stressors on psychosis risk has usually been studied in isolation and after the onset of the disorder, potentially ignoring important confounding relationships or the fact that some stressors that may be the consequence of the disorder rather than preexisting. The study of subclinical psychosis could help to address some of these issues. In this study, we investigated whether there was (i) an association between dimensions of subclinical psychosis and several psychosocial stressors including: childhood trauma, self-reported discrimination experiences, low social capital, and stressful life experiences, and (ii) any evidence of environment-environment (ExE) inte…

Malestressful life eventsSchizotypypositive subclinical symptomEthnic groupSocial Environmentsubclinical psychosispositive subclinical symptoms0302 clinical medicineAdverse Childhood ExperiencesSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.SINTOMAS PSÍQUICOSsubclinical psychosi10. No inequalityCOMMUNITY ASSESSMENTSubclinical infectionGENERAL-POPULATIONpsychotic symptomDepressionConfoundingSocial Discriminationdepressive subclinical symptomstressful life eventETHNIC-GROUPS3. Good healthPsychiatry and Mental healthNEIGHBORHOOD CHARACTERISTICSADULT PSYCHIATRIC-DISORDERSpsychotic symptomsAdverse Childhood ExperienceFemalepsychosocial stressPsychologyPsychosocialHumanClinical psychologynegative subclinical symptompsychosocial streAdultPsychosisSiblingLIFE EVENTSschizotypyPsychotic Disorder03 medical and health sciencesCommunity Assessment of Psychic Experiences (CAPE)THREATENING EXPERIENCESmedicineHumansEuropean UnionSiblingSettore MED/25 - Psichiatriachildhood traumaSiblingsStressormedicine.diseasePERCEIVED DISCRIMINATIONnegative subclinical symptoms030227 psychiatryPSYCHOMETRIC PROPERTIESPsychotic Disorders[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthdis criminationsocial capitaldepressive subclinical symptomsStress Psychological030217 neurology & neurosurgeryRegular Articlesdiscrimination
researchProduct

The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: findings from the multinational EU-GEI study

2022

AbstractBackgroundIn Europe, the incidence of psychotic disorder is high in certain migrant and minority ethnic groups (hence: ‘minorities’). However, it is unknown how the incidence pattern for these groups varies within this continent. Our objective was to compare, across sites in France, Italy, Spain, the UK and the Netherlands, the incidence rates for minorities and the incidence rate ratios (IRRs, minorities v. the local reference population).MethodsThe European Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI) study was conducted between 2010 and 2015. We analyzed data on incident cases of non-organic psychosis (International Classification of …

medicine.medical_specialtyDopamineRegion of originEthnic groupmigrationpsychosistress03 medical and health sciencesRace (biology)0302 clinical medicineEpidemiologymedicineHumanspsychosis10. No inequalityraceMinority GroupsApplied PsychologyTransients and MigrantsHigh rateIncidenceIncidence (epidemiology)Social environmentPREVALENCE030227 psychiatry3. Good healthEuropeschizophreniaPsychiatry and Mental healthGeographyPsychotic DisordersMultinational corporation1ST-CONTACT INCIDENCEethnicityepidemiology030217 neurology & neurosurgerySOCIAL DEFEAT HYPOTHESISDemographyPsychological Medicine
researchProduct

Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain.

2014

Genome wide association studies (GWAS) has allowed the discovery of some interesting risk variants for schizophrenia (SCZ). However, this high-throughput approach presents some limitations, being the most important the necessity of highly restrictive statistical corrections as well as the loss of statistical power inherent to the use of a Single Nucleotide Polymorphism (SNP) analysis approach. These problems can be partially solved through the use of a polygenic approach. We performed a genotyping study in SCZ using 86 previously associated SNPs identified by GWAS of SCZ, bipolar disorder (BPD) and autistic spectrum disorder (ASD) patients. The sample consisted of 3063 independent cases wit…

AdultMaleMultifactorial InheritanceAdolescentBipolar disorderSingle-nucleotide polymorphismGenome-wide association studyBiologyPolymorphism Single NucleotideODZ4White PeopleYoung AdultPolygenic scoremedicineGWASSNPHumansGenetic Predisposition to DiseaseBipolar disorderAlleleGenotypingBiological PsychiatryAgedGeneticsAged 80 and overMembrane GlycoproteinsModels GeneticCase-control studyMiddle Agedmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaSpainArea Under CurveCase-Control StudiesReplication studySchizophreniaFemaleGenome-Wide Association StudySchizophrenia research
researchProduct

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: results from the…

2021

European Community's Seventh Framework Program, European Commission [HEALTH-F2-2009-241909]; Scientific and Technological Research Council of Turkey, 2219 International Postdoctoral Research Fellowship Program; Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, and PI19/024)...

cannabisPsychosisExposomeSYMPTOMSGlobal Assessment of Functioning1ST EPISODEGENETIC RISKVALIDATIONfunctioning03 medical and health sciences0302 clinical medicineCovariatemedicineHumanspsychosisPsiquiatriaPOPULATIONchildhood traumabiologybusiness.industryGLOBAL ASSESSMENTSiblingsRegression analysisEnvironmental exposuremedicine.diseasebiology.organism_classification3. Good health030227 psychiatryPsychiatry and Mental healthExposomeCross-Sectional StudiesPsychotic DisordersSchizophreniaRELIABILITYSchizophreniaCannabisCANNABIS USE DISORDERSbusinessenvironment030217 neurology & neurosurgeryClinical psychologyResearch Article
researchProduct

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

2019

Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder. Methods: We included patients aged 18–64 years who presented to psychiatric services in 11 sites across Europe and Brazil with first-episode psychosis and recruited controls representative of the local populations. We applied adjusted logistic regression models to the data to estimate which patterns of canna…

MaleMarijuana Abusecannabis psychosis first episode psychosis incidenceENGLANDHIGH-POTENCY CANNABIS0302 clinical medicineSCHIZOPHRENIAOdds RatioMedicine030212 general & internal medicinepsychosisSalut mentalRISKeducation.field_of_studybiologyIncidence (epidemiology)IncidenceArticlesASSOCIATIONMiddle Aged3. Good healthEuropePsychiatry and Mental healthPUBLIC-HEALTHFemaleCase-Control StudieBrazilHumanAdultmedicine.medical_specialtyPsychosisPopulationPsychotic DisorderOdds03 medical and health sciencesYoung Adultfirst episode psychosisJournal ArticleHumanseducationSettore MED/25 - PsichiatriaBiological PsychiatryCannabisbusiness.industryLONDONPublic healthCase-control studyOdds ratiobiology.organism_classificationmedicine.diseaseTRENDS030227 psychiatryPsychotic DisordersMARIJUANACase-Control StudiesCannabisDroguesbusinessDemography
researchProduct

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

2014

European Community Recent years have seen considerable progress in epidemiological and molecular genetic research into environmental and genetic factors in schizophrenia, but methodological uncertainties remain with regard to validating environmental exposures, and the population risk conferred by individual molecular genetic variants is small. There are now also a limited number of studies that have investigated molecular genetic candidate gene-environment interactions (G x E), however, so far, thorough replication of findings is rare and G x E research still faces several conceptual and methodological challenges. in this article, we aim to review these recent developments and illustrate h…

URBANICITYSchizophrenia (object-oriented programming)CHILDHOODGenome-wide association studyVARIANTSSocial Environmentpsychosi03 medical and health sciences0302 clinical medicinePSYCHOSISepidemiology; gene-environment interaction; genetics; psychosis; schizophreniaSDG 3 - Good Health and Well-beingRISK-FACTORSettore M-PSI/08 - Psicologia ClinicaGenetic variationHumansGenetic Predisposition to DiseasegeneticspsychosisGENOME-WIDE ASSOCIATIONGeneSettore MED/25 - PsichiatriaMETAANALYSISScale (chemistry)schizophrenia; gene-environment interaction; Psychosis; epidemiology; geneticsGenetic variantsEnvironment and Schizophrenia InvitedCANNABIS USE3. Good health030227 psychiatrygene-environment interactionschizophreniaPsychiatry and Mental healthEvolutionary biology/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingIdentification (biology)Schizophrenic PsychologyepidemiologyPopulation RiskgeneticPsychologyFOLLOW-UP030217 neurology & neurosurgeryFUTURE-DIRECTIONSClinical psychology
researchProduct

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode ps…

2021

The work was supported by Guarantors of Brain post-doctoral clinical fellowship to DQ; Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; Heisenberg professorship from the German Research Founda- tion (grant no. 389624707) to UR; the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-…

medicine.medical_specialtyPsychosisPopulationNeurosciences. Biological psychiatry. NeuropsychiatryPHENOTYPESILLNESSPsychotic DisorderPredictive markersArticleCellular and Molecular NeuroscienceDEFICIT SYNDROMERisk FactorsFirst episode psychosismedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCannabiClinical geneticsGenetic riskVALIDITYeducationSettore MED/25 - PsichiatriaSCHEDULEBiological PsychiatryMETAANALYSISCannabisUTILITYeducation.field_of_studyRisk FactorESQUIZOFRENIAASSOCIATIONCannabis usemedicine.diseaseBIFACTOR MODELPsychiatry and Mental healthPsychotic DisordersINTERRATER RELIABILITYSchizophreniaLinear ModelsSchizophreniaLinear ModelMedical geneticsPolygenic risk scorePsychologyHumanRC321-571Clinical psychology
researchProduct